> top > docs > PubMed:10336989 > annotations

PubMed:10336989 JSONTXT

Annnotations TAB JSON ListView MergeView

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-216 Sentence denotes Expression of the insulin-like growth factor 1 receptor (IGF-1R) in breast cancer cells: evidence for a regulatory role of dolichyl phosphate in the transition from an intracellular to an extracellular IGF-1 pathway.
TextSentencer_T2 217-413 Sentence denotes In this study we provide evidence that the low expression of IGF-1R at the cell surface of estrogen-independent breast cancer cells is due to a low rate of de novo synthesis of dolichyl phosphate.
TextSentencer_T3 414-622 Sentence denotes The analyses were performed on the estrogen receptor-negative breast cancer cell line MDA231 and, in comparison, the melanoma cell line SK-MEL-2, which expresses a high number of plasma membrane-bound IGF-1R.
TextSentencer_T4 623-768 Sentence denotes Whereas the MDA231 cells had little or no surface expression of IGF-1R, they expressed functional (i.e., ligand-binding) intracellular receptors.
TextSentencer_T5 769-972 Sentence denotes By measuring the incorporation of [3H]mevalonate into dolichyl phosphate, we could demonstrate that the rate of dolichyl phosphate synthesis was considerably lower in MDA231 cells than in SK-MEL-2 cells.
TextSentencer_T6 973-1080 Sentence denotes Furthermore, N-linked glycosylation of the alpha-subunit of IGF-1R was 8-fold higher in the melanoma cells.
TextSentencer_T7 1081-1382 Sentence denotes Following addition of dolichyl phosphate to MDA231 cells, N-linked glycosylation of IGF-1R was drastically increased, which in turn was correlated to a substantial translocation of IGF-1R to the plasma membrane, as assayed by IGF-1 binding analysis and by Western blotting of plasma membrane proteins.
TextSentencer_T8 1383-1507 Sentence denotes The dolichyl phosphate-stimulated receptors were proven to be biochemically active since they exhibited autophosphorylation.
TextSentencer_T9 1508-1686 Sentence denotes Under normal conditions MDA231 cells, expressing very few IGF-1R at the cell surface, were not growth-arrested by an antibody (alphaIR-3) blocking the binding of IGF-1 to IGF-1R.
TextSentencer_T10 1687-1839 Sentence denotes However, after treatment with dolichyl phosphate, leading to a high cell surface expression of IGF-1R, alphaIR-3 efficiently blocked MDA231 cell growth.
TextSentencer_T11 1840-2130 Sentence denotes Taken together with the fact that the breast cancer cells produce IGF-1 and exhibit intracellular binding, our data suggest that the level of de novo -synthesized dolichyl phosphate may be critical for whether the cells will use an intracellular or an extracellular autocrine IGF-1 pathway.
T1 0-216 Sentence denotes Expression of the insulin-like growth factor 1 receptor (IGF-1R) in breast cancer cells: evidence for a regulatory role of dolichyl phosphate in the transition from an intracellular to an extracellular IGF-1 pathway.
T2 217-413 Sentence denotes In this study we provide evidence that the low expression of IGF-1R at the cell surface of estrogen-independent breast cancer cells is due to a low rate of de novo synthesis of dolichyl phosphate.
T3 414-622 Sentence denotes The analyses were performed on the estrogen receptor-negative breast cancer cell line MDA231 and, in comparison, the melanoma cell line SK-MEL-2, which expresses a high number of plasma membrane-bound IGF-1R.
T4 623-768 Sentence denotes Whereas the MDA231 cells had little or no surface expression of IGF-1R, they expressed functional (i.e., ligand-binding) intracellular receptors.
T5 769-972 Sentence denotes By measuring the incorporation of [3H]mevalonate into dolichyl phosphate, we could demonstrate that the rate of dolichyl phosphate synthesis was considerably lower in MDA231 cells than in SK-MEL-2 cells.
T6 973-1080 Sentence denotes Furthermore, N-linked glycosylation of the alpha-subunit of IGF-1R was 8-fold higher in the melanoma cells.
T7 1081-1382 Sentence denotes Following addition of dolichyl phosphate to MDA231 cells, N-linked glycosylation of IGF-1R was drastically increased, which in turn was correlated to a substantial translocation of IGF-1R to the plasma membrane, as assayed by IGF-1 binding analysis and by Western blotting of plasma membrane proteins.
T8 1383-1507 Sentence denotes The dolichyl phosphate-stimulated receptors were proven to be biochemically active since they exhibited autophosphorylation.
T9 1508-1686 Sentence denotes Under normal conditions MDA231 cells, expressing very few IGF-1R at the cell surface, were not growth-arrested by an antibody (alphaIR-3) blocking the binding of IGF-1 to IGF-1R.
T10 1687-1839 Sentence denotes However, after treatment with dolichyl phosphate, leading to a high cell surface expression of IGF-1R, alphaIR-3 efficiently blocked MDA231 cell growth.
T11 1840-2130 Sentence denotes Taken together with the fact that the breast cancer cells produce IGF-1 and exhibit intracellular binding, our data suggest that the level of de novo -synthesized dolichyl phosphate may be critical for whether the cells will use an intracellular or an extracellular autocrine IGF-1 pathway.
T1 0-216 Sentence denotes Expression of the insulin-like growth factor 1 receptor (IGF-1R) in breast cancer cells: evidence for a regulatory role of dolichyl phosphate in the transition from an intracellular to an extracellular IGF-1 pathway.
T2 217-413 Sentence denotes In this study we provide evidence that the low expression of IGF-1R at the cell surface of estrogen-independent breast cancer cells is due to a low rate of de novo synthesis of dolichyl phosphate.
T3 414-622 Sentence denotes The analyses were performed on the estrogen receptor-negative breast cancer cell line MDA231 and, in comparison, the melanoma cell line SK-MEL-2, which expresses a high number of plasma membrane-bound IGF-1R.
T4 623-768 Sentence denotes Whereas the MDA231 cells had little or no surface expression of IGF-1R, they expressed functional (i.e., ligand-binding) intracellular receptors.
T5 769-972 Sentence denotes By measuring the incorporation of [3H]mevalonate into dolichyl phosphate, we could demonstrate that the rate of dolichyl phosphate synthesis was considerably lower in MDA231 cells than in SK-MEL-2 cells.
T6 973-1080 Sentence denotes Furthermore, N-linked glycosylation of the alpha-subunit of IGF-1R was 8-fold higher in the melanoma cells.
T7 1081-1382 Sentence denotes Following addition of dolichyl phosphate to MDA231 cells, N-linked glycosylation of IGF-1R was drastically increased, which in turn was correlated to a substantial translocation of IGF-1R to the plasma membrane, as assayed by IGF-1 binding analysis and by Western blotting of plasma membrane proteins.
T8 1383-1507 Sentence denotes The dolichyl phosphate-stimulated receptors were proven to be biochemically active since they exhibited autophosphorylation.
T9 1508-1686 Sentence denotes Under normal conditions MDA231 cells, expressing very few IGF-1R at the cell surface, were not growth-arrested by an antibody (alphaIR-3) blocking the binding of IGF-1 to IGF-1R.
T10 1687-1839 Sentence denotes However, after treatment with dolichyl phosphate, leading to a high cell surface expression of IGF-1R, alphaIR-3 efficiently blocked MDA231 cell growth.
T11 1840-2130 Sentence denotes Taken together with the fact that the breast cancer cells produce IGF-1 and exhibit intracellular binding, our data suggest that the level of de novo -synthesized dolichyl phosphate may be critical for whether the cells will use an intracellular or an extracellular autocrine IGF-1 pathway.

GlycoBiology-FMA

Id Subject Object Predicate Lexical cue
_T1 18-25 FMAID:83365 denotes insulin
_T2 18-25 FMAID:197650 denotes insulin
_T3 45-55 FMAID:166248 denotes 1 receptor
_T4 45-55 FMAID:61983 denotes 1 receptor
_T5 45-55 FMAID:166257 denotes 1 receptor
_T6 45-55 FMAID:61986 denotes 1 receptor
_T7 68-74 FMAID:9601 denotes breast
_T8 68-74 FMAID:97486 denotes breast
_T9 82-87 FMAID:169002 denotes cells
_T10 82-87 FMAID:68646 denotes cells
_T11 149-159 FMAID:171495 denotes transition
_T12 149-159 FMAID:70637 denotes transition
_T13 168-201 FMAID:201486 denotes intracellular to an extracellular
_T14 168-201 FMAID:165931 denotes intracellular to an extracellular
_T15 168-201 FMAID:67946 denotes intracellular to an extracellular
_T16 168-201 FMAID:70022 denotes intracellular to an extracellular
_T17 168-201 FMAID:170759 denotes intracellular to an extracellular
_T18 292-304 FMAID:200942 denotes cell surface
_T19 292-304 FMAID:212684 denotes cell surface
_T20 297-304 FMAID:146300 denotes surface
_T21 297-304 FMAID:50594 denotes surface
_T22 308-316 FMAID:197661 denotes estrogen
_T23 308-316 FMAID:83376 denotes estrogen
_T24 329-335 FMAID:9601 denotes breast
_T25 329-335 FMAID:97486 denotes breast
_T26 343-348 FMAID:68646 denotes cells
_T27 343-348 FMAID:169002 denotes cells
_T28 365-369 FMAID:217859 denotes rate
_T29 449-457 FMAID:83376 denotes estrogen
_T30 449-457 FMAID:197661 denotes estrogen
_T31 476-482 FMAID:97486 denotes breast
_T32 476-482 FMAID:9601 denotes breast
_T33 583-608 FMAID:67269 denotes number of plasma membrane
_T34 583-608 FMAID:165262 denotes number of plasma membrane
_T35 590-608 FMAID:199971 denotes of plasma membrane
_T36 590-608 FMAID:85546 denotes of plasma membrane
_T37 590-608 FMAID:67656 denotes of plasma membrane
_T38 590-608 FMAID:199169 denotes of plasma membrane
_T39 590-608 FMAID:63187 denotes of plasma membrane
_T40 590-608 FMAID:167581 denotes of plasma membrane
_T41 590-608 FMAID:165573 denotes of plasma membrane
_T42 590-608 FMAID:199168 denotes of plasma membrane
_T43 593-599 FMAID:162307 denotes plasma
_T44 593-608 FMAID:162306 denotes plasma membrane
_T45 593-608 FMAID:166047 denotes plasma membrane
_T46 593-608 FMAID:63841 denotes plasma membrane
_T47 593-608 FMAID:164993 denotes plasma membrane
_T48 593-608 FMAID:66843 denotes plasma membrane
_T49 593-608 FMAID:210691 denotes plasma membrane
_T50 642-647 FMAID:68646 denotes cells
_T51 642-647 FMAID:169002 denotes cells
_T52 665-672 FMAID:146300 denotes surface
_T53 665-672 FMAID:50594 denotes surface
_T54 873-877 FMAID:217859 denotes rate
_T55 943-948 FMAID:169002 denotes cells
_T56 943-948 FMAID:68646 denotes cells
_T57 966-971 FMAID:68646 denotes cells
_T58 966-971 FMAID:169002 denotes cells
_T59 1074-1079 FMAID:68646 denotes cells
_T60 1074-1079 FMAID:169002 denotes cells
_T61 1132-1137 FMAID:169002 denotes cells
_T62 1132-1137 FMAID:68646 denotes cells
_T63 1233-1244 FMAID:188924 denotes substantial
_T64 1276-1282 FMAID:162307 denotes plasma
_T65 1276-1291 FMAID:162306 denotes plasma membrane
_T66 1276-1291 FMAID:164993 denotes plasma membrane
_T67 1276-1291 FMAID:63841 denotes plasma membrane
_T68 1276-1291 FMAID:166047 denotes plasma membrane
_T69 1276-1291 FMAID:210691 denotes plasma membrane
_T70 1276-1291 FMAID:66843 denotes plasma membrane
_T71 1357-1363 FMAID:162307 denotes plasma
_T72 1357-1381 FMAID:198531 denotes plasma membrane proteins
_T73 1357-1381 FMAID:66843 denotes plasma membrane proteins
_T74 1357-1381 FMAID:67858 denotes plasma membrane proteins
_T75 1357-1381 FMAID:63020 denotes plasma membrane proteins
_T76 1357-1381 FMAID:164993 denotes plasma membrane proteins
_T77 1357-1381 FMAID:167401 denotes plasma membrane proteins
_T78 1364-1381 FMAID:89997 denotes membrane proteins
_T79 1364-1381 FMAID:198528 denotes membrane proteins
_T80 1373-1381 FMAID:165447 denotes proteins
_T81 1373-1381 FMAID:67257 denotes proteins
_T82 1539-1544 FMAID:169002 denotes cells
_T83 1539-1544 FMAID:68646 denotes cells
_T84 1580-1592 FMAID:200942 denotes cell surface
_T85 1580-1592 FMAID:212684 denotes cell surface
_T86 1585-1592 FMAID:50594 denotes surface
_T87 1585-1592 FMAID:146300 denotes surface
_T88 1625-1633 FMAID:167180 denotes antibody
_T89 1755-1767 FMAID:212684 denotes cell surface
_T90 1755-1767 FMAID:200942 denotes cell surface
_T91 1760-1767 FMAID:146300 denotes surface
_T92 1760-1767 FMAID:50594 denotes surface
_T93 1878-1884 FMAID:9601 denotes breast
_T94 1878-1884 FMAID:97486 denotes breast
_T95 1892-1897 FMAID:169002 denotes cells
_T96 1892-1897 FMAID:68646 denotes cells
_T97 2054-2059 FMAID:68646 denotes cells
_T98 2054-2059 FMAID:169002 denotes cells
_T99 2072-2105 FMAID:70022 denotes intracellular or an extracellular
_T100 2072-2105 FMAID:170759 denotes intracellular or an extracellular
_T101 2072-2105 FMAID:67946 denotes intracellular or an extracellular
_T102 2072-2105 FMAID:165931 denotes intracellular or an extracellular
_T103 2072-2105 FMAID:201486 denotes intracellular or an extracellular

uniprot-human

Id Subject Object Predicate Lexical cue
T1 18-25 http://www.uniprot.org/uniprot/P01308 denotes insulin
T2 31-46 http://www.uniprot.org/uniprot/P13385 denotes growth factor 1
T3 31-46 http://www.uniprot.org/uniprot/Q99684 denotes growth factor 1
T4 31-46 http://www.uniprot.org/uniprot/P05230 denotes growth factor 1
T5 31-46 http://www.uniprot.org/uniprot/P28069 denotes growth factor 1
T6 31-55 http://www.uniprot.org/uniprot/Q9UDF2 denotes growth factor 1 receptor
T7 38-55 http://www.uniprot.org/uniprot/Q5T3J3 denotes factor 1 receptor
T8 449-466 http://www.uniprot.org/uniprot/P03372 denotes estrogen receptor
T9 476-494 http://www.uniprot.org/uniprot/Q8IZY5 denotes breast cancer cell
T10 550-552 http://www.uniprot.org/uniprot/O94907 denotes SK
T11 957-959 http://www.uniprot.org/uniprot/O94907 denotes SK
T12 550-552 http://www.uniprot.org/uniprot/Q92952 denotes SK
T13 957-959 http://www.uniprot.org/uniprot/Q92952 denotes SK
T14 553-556 http://www.uniprot.org/uniprot/P61006 denotes MEL
T15 960-963 http://www.uniprot.org/uniprot/P61006 denotes MEL
T16 1307-1320 http://www.uniprot.org/uniprot/P08833 denotes IGF-1 binding
T17 1659-1675 http://www.uniprot.org/uniprot/P08833 denotes binding of IGF-1

uniprot-mouse

Id Subject Object Predicate Lexical cue
T1 449-466 http://www.uniprot.org/uniprot/P19785 denotes estrogen receptor
T2 1307-1320 http://www.uniprot.org/uniprot/P47876 denotes IGF-1 binding
T3 1659-1675 http://www.uniprot.org/uniprot/P47876 denotes binding of IGF-1

GlycoBiology-NCBITAXON

Id Subject Object Predicate Lexical cue
T1 75-81 http://purl.bioontology.org/ontology/NCBITAXON/6754 denotes cancer
T2 82-87 http://purl.bioontology.org/ontology/STY/T025 denotes cells
T3 336-342 http://purl.bioontology.org/ontology/NCBITAXON/6754 denotes cancer
T4 343-348 http://purl.bioontology.org/ontology/STY/T025 denotes cells
T5 483-489 http://purl.bioontology.org/ontology/NCBITAXON/6754 denotes cancer
T6 531-539 http://purl.bioontology.org/ontology/NCBITAXON/45308 denotes melanoma
T7 531-539 http://purl.bioontology.org/ontology/NCBITAXON/1369386 denotes melanoma
T8 642-647 http://purl.bioontology.org/ontology/STY/T025 denotes cells
T9 758-767 http://purl.bioontology.org/ontology/STY/T192 denotes receptors
T10 943-948 http://purl.bioontology.org/ontology/STY/T025 denotes cells
T11 966-971 http://purl.bioontology.org/ontology/STY/T025 denotes cells
T12 1065-1073 http://purl.bioontology.org/ontology/NCBITAXON/45308 denotes melanoma
T13 1065-1073 http://purl.bioontology.org/ontology/NCBITAXON/1369386 denotes melanoma
T14 1074-1079 http://purl.bioontology.org/ontology/STY/T025 denotes cells
T15 1132-1137 http://purl.bioontology.org/ontology/STY/T025 denotes cells
T16 1417-1426 http://purl.bioontology.org/ontology/STY/T192 denotes receptors
T17 1539-1544 http://purl.bioontology.org/ontology/STY/T025 denotes cells
T18 1885-1891 http://purl.bioontology.org/ontology/NCBITAXON/6754 denotes cancer
T19 1892-1897 http://purl.bioontology.org/ontology/STY/T025 denotes cells
T20 2054-2059 http://purl.bioontology.org/ontology/STY/T025 denotes cells

GO-BP

Id Subject Object Predicate Lexical cue
T1 31-37 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T2 1603-1609 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T3 1832-1838 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T4 381-390 http://purl.obolibrary.org/obo/GO_0009058 denotes synthesis
T5 900-909 http://purl.obolibrary.org/obo/GO_0009058 denotes synthesis
T6 995-1008 http://purl.obolibrary.org/obo/GO_0070085 denotes glycosylation
T7 1148-1161 http://purl.obolibrary.org/obo/GO_0070085 denotes glycosylation
T8 1357-1381 http://purl.obolibrary.org/obo/GO_0098737 denotes plasma membrane proteins
T9 1357-1381 http://purl.obolibrary.org/obo/GO_0072661 denotes plasma membrane proteins
T10 1357-1381 http://purl.obolibrary.org/obo/GO_0072659 denotes plasma membrane proteins
T11 1827-1838 http://purl.obolibrary.org/obo/GO_0016049 denotes cell growth

GO-MF

Id Subject Object Predicate Lexical cue
T1 728-734 http://purl.obolibrary.org/obo/GO_0005488 denotes ligand
T2 735-742 http://purl.obolibrary.org/obo/GO_0070026 denotes binding
T3 1313-1320 http://purl.obolibrary.org/obo/GO_0070026 denotes binding
T4 1659-1666 http://purl.obolibrary.org/obo/GO_0070026 denotes binding
T5 1938-1945 http://purl.obolibrary.org/obo/GO_0070026 denotes binding
T6 735-742 http://purl.obolibrary.org/obo/GO_0003680 denotes binding
T7 1313-1320 http://purl.obolibrary.org/obo/GO_0003680 denotes binding
T8 1659-1666 http://purl.obolibrary.org/obo/GO_0003680 denotes binding
T9 1938-1945 http://purl.obolibrary.org/obo/GO_0003680 denotes binding
T10 735-742 http://purl.obolibrary.org/obo/GO_0017091 denotes binding
T11 1313-1320 http://purl.obolibrary.org/obo/GO_0017091 denotes binding
T12 1659-1666 http://purl.obolibrary.org/obo/GO_0017091 denotes binding
T13 1938-1945 http://purl.obolibrary.org/obo/GO_0017091 denotes binding
T14 735-742 http://purl.obolibrary.org/obo/GO_0005488 denotes binding
T15 1313-1320 http://purl.obolibrary.org/obo/GO_0005488 denotes binding
T16 1659-1666 http://purl.obolibrary.org/obo/GO_0005488 denotes binding
T17 1938-1945 http://purl.obolibrary.org/obo/GO_0005488 denotes binding
T18 1625-1633 http://purl.obolibrary.org/obo/GO_0003823 denotes antibody
T19 1659-1673 http://purl.obolibrary.org/obo/GO_0005520 denotes binding of IGF

GO-CC

Id Subject Object Predicate Lexical cue
T1 82-87 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T2 343-348 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T3 642-647 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T4 943-948 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T5 966-971 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T6 1074-1079 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T7 1132-1137 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T8 1539-1544 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T9 1892-1897 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T10 292-296 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T11 490-494 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T12 540-544 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T13 1580-1584 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T14 1755-1759 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T15 1827-1831 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T16 168-181 http://purl.obolibrary.org/obo/GO_0005622 denotes intracellular
T17 744-757 http://purl.obolibrary.org/obo/GO_0005622 denotes intracellular
T18 1924-1937 http://purl.obolibrary.org/obo/GO_0005622 denotes intracellular
T19 2072-2085 http://purl.obolibrary.org/obo/GO_0005622 denotes intracellular
T20 188-201 http://purl.obolibrary.org/obo/GO_0005576 denotes extracellular
T21 2092-2105 http://purl.obolibrary.org/obo/GO_0005576 denotes extracellular
T22 292-304 http://purl.obolibrary.org/obo/GO_0009986 denotes cell surface
T23 1580-1592 http://purl.obolibrary.org/obo/GO_0009986 denotes cell surface
T24 1755-1767 http://purl.obolibrary.org/obo/GO_0009986 denotes cell surface
T25 593-608 http://purl.obolibrary.org/obo/GO_0005886 denotes plasma membrane
T26 1276-1291 http://purl.obolibrary.org/obo/GO_0005886 denotes plasma membrane
T27 1357-1372 http://purl.obolibrary.org/obo/GO_0005886 denotes plasma membrane
T28 600-608 http://purl.obolibrary.org/obo/GO_0016020 denotes membrane
T29 1283-1291 http://purl.obolibrary.org/obo/GO_0016020 denotes membrane
T30 1364-1372 http://purl.obolibrary.org/obo/GO_0016020 denotes membrane
T31 1357-1381 http://purl.obolibrary.org/obo/GO_0019897 denotes plasma membrane proteins
T32 1357-1381 http://purl.obolibrary.org/obo/GO_0098797 denotes plasma membrane proteins

UBERON-AE

Id Subject Object Predicate Lexical cue
T1 68-74 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
T2 329-335 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
T3 476-482 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
T4 1878-1884 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast

EDAM-topics

Id Subject Object Predicate Lexical cue
T1 75-81 http://edamontology.org/topic_2640 denotes cancer
T2 208-215 http://edamontology.org/topic_0602 denotes pathway
T3 225-230 http://edamontology.org/topic_3678 denotes study
T4 336-342 http://edamontology.org/topic_2640 denotes cancer
T5 483-489 http://edamontology.org/topic_2640 denotes cancer
T6 1364-1381 http://edamontology.org/topic_0820 denotes membrane proteins
T7 1373-1381 http://edamontology.org/topic_0078 denotes proteins
T8 1885-1891 http://edamontology.org/topic_2640 denotes cancer
T9 2122-2129 http://edamontology.org/topic_0602 denotes pathway

EDAM-DFO

Id Subject Object Predicate Lexical cue
T1 208-215 http://edamontology.org/data_2600 denotes pathway
T2 515-525 http://edamontology.org/operation_2424 denotes comparison
T3 772-781 http://edamontology.org/data_3108 denotes measuring
T4 852-863 http://edamontology.org/operation_2246 denotes demonstrate
T5 1217-1227 http://edamontology.org/operation_3465 denotes correlated
T6 1321-1329 http://edamontology.org/operation_2945 denotes analysis
T7 1373-1381 http://edamontology.org/data_1467 denotes proteins
T8 1373-1381 http://edamontology.org/format_1208 denotes proteins
T9 1514-1520 http://edamontology.org/operation_3435 denotes normal
T10 1951-1955 http://edamontology.org/data_0006 denotes data
T11 2122-2129 http://edamontology.org/data_2600 denotes pathway

performance-test

Id Subject Object Predicate Lexical cue
PD-UBERON-AE-B_T1 68-74 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T2 329-335 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T3 476-482 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T4 1878-1884 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 329-342 HP_0003002 denotes breast cancer
T2 329-342 HP_0100013 denotes breast cancer
T3 336-342 HP_0002664 denotes cancer
T4 476-489 HP_0003002 denotes breast cancer
T5 476-489 HP_0100013 denotes breast cancer
T6 483-489 HP_0002664 denotes cancer
T7 531-539 HP_0002861 denotes melanoma
T8 1065-1073 HP_0002861 denotes melanoma
T9 1878-1891 HP_0003002 denotes breast cancer
T10 1878-1891 HP_0100013 denotes breast cancer
T11 1885-1891 HP_0002664 denotes cancer

mondo_disease

Id Subject Object Predicate Lexical cue mondo_id
T1 68-81 Disease denotes breast cancer http://purl.obolibrary.org/obo/MONDO_0007254
T2 329-342 Disease denotes breast cancer http://purl.obolibrary.org/obo/MONDO_0007254
T3 449-489 Disease denotes estrogen receptor-negative breast cancer http://purl.obolibrary.org/obo/MONDO_0006513
T4 531-539 Disease denotes melanoma http://purl.obolibrary.org/obo/MONDO_0005105
T5 1065-1073 Disease denotes melanoma http://purl.obolibrary.org/obo/MONDO_0005105
T6 1878-1891 Disease denotes breast cancer http://purl.obolibrary.org/obo/MONDO_0007254

GlyCosmos15-HP

Id Subject Object Predicate Lexical cue hp_id
T1 68-81 Phenotype denotes breast cancer HP:0003002
T2 329-342 Phenotype denotes breast cancer HP:0003002
T3 476-489 Phenotype denotes breast cancer HP:0003002
T4 531-539 Phenotype denotes melanoma HP:0002861
T5 1065-1073 Phenotype denotes melanoma HP:0002861
T6 1878-1891 Phenotype denotes breast cancer HP:0003002

Anatomy-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 68-74 Body_part denotes breast http://purl.obolibrary.org/obo/UBERON_0000310
T2 168-181 Body_part denotes intracellular http://purl.obolibrary.org/obo/GO_0005622
T3 188-201 Body_part denotes extracellular http://purl.obolibrary.org/obo/GO_0005576
T4 329-335 Body_part denotes breast http://purl.obolibrary.org/obo/UBERON_0000310
T5 476-482 Body_part denotes breast http://purl.obolibrary.org/obo/UBERON_0000310
T6 593-608 Body_part denotes plasma membrane http://purl.obolibrary.org/obo/GO_0005886
T7 744-757 Body_part denotes intracellular http://purl.obolibrary.org/obo/GO_0005622
T8 1276-1291 Body_part denotes plasma membrane http://purl.obolibrary.org/obo/GO_0005886
T9 1357-1372 Body_part denotes plasma membrane http://purl.obolibrary.org/obo/GO_0005886
T10 1878-1884 Body_part denotes breast http://purl.obolibrary.org/obo/UBERON_0000310
T11 1924-1937 Body_part denotes intracellular http://purl.obolibrary.org/obo/GO_0005622
T12 2072-2085 Body_part denotes intracellular http://purl.obolibrary.org/obo/GO_0005622
T13 2092-2105 Body_part denotes extracellular http://purl.obolibrary.org/obo/GO_0005576

Glycosmos15-CL

Id Subject Object Predicate Lexical cue cl_id
T1 75-87 Cell denotes cancer cells http://purl.obolibrary.org/obo/CL:0001064
T2 336-348 Cell denotes cancer cells http://purl.obolibrary.org/obo/CL:0001064
T3 483-494 Cell denotes cancer cell http://purl.obolibrary.org/obo/CL:0001064
T4 1885-1897 Cell denotes cancer cells http://purl.obolibrary.org/obo/CL:0001064